The synthetic Thymosin Beta-4 fragment banned in horse racing and hyped as the other half of the “Wolverine Stack.” Here is what the science actually supports.
TB-500 is a synthetic version of Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid peptide produced primarily by the thymus gland. TB4 is one of the most abundant intracellular proteins in mammalian cells and is found in nearly every tissue in the body.
The primary biological function of TB4 is actin sequestration — it binds to a protein called G-actin and regulates how cells build their internal structure (the cytoskeleton). This matters because the cytoskeleton drives cell migration: when tissue is damaged, cells need to physically move to the wound site to begin repair. TB4 is one of the key regulators of that process.
TB-500 is not the full TB4 protein. It is a synthetic fragment that contains the active region responsible for the actin-binding and cell-migration properties. The name “TB-500” is a commercial/community designation — the scientific literature refers to the parent molecule as Thymosin Beta-4 or Tβ4.
Like BPC-157, TB-500 is not FDA-approved for any indication. It is available as a research chemical and through compounding pharmacies. It gained widespread attention after being banned in horse racing and becoming a staple of online peptide communities.
From Reddit threads, peptide forums, and influencer content. The horse racing angle makes TB-500 especially prone to exaggeration.
TB-500 heals everything that BPC-157 misses. It is the single best compound for systemic recovery, period.
TB-500 is what professional athletes and billion-dollar racehorses use to recover faster. If it is good enough for a million-dollar horse, it is good enough for you.
Stack TB-500 with BPC-157 and you have the "Wolverine Stack" — the most powerful healing combination known to biohacking. Covers local and systemic healing simultaneously.
Unlike BPC-157 which works locally, TB-500 travels systemically and heals everything at once — joints, muscles, tendons, organs, even your brain.
TB-500 can actually regenerate damaged heart muscle. People use it after cardiac events to rebuild their heart tissue.
Your body already produces Thymosin Beta-4, so supplementing with TB-500 is just giving your body more of what it already makes. Zero risk.
TB-500 regrows hair by activating stem cells in follicles. Multiple Reddit threads confirm thicker, fuller hair within weeks.
You can feel TB-500 working within 24-48 hours. Recovery from injuries that would take months happens in weeks.
Real biology, real studies, real limitations. The science is thinner than you have been told.
TB-500 is a synthetic version of a 43-amino-acid peptide called Thymosin Beta-4 (TB4), which is naturally produced by the thymus gland and found in virtually all human cells. TB4 is one of the most abundant intracellular proteins and plays a well-documented role in actin polymerization — the process by which cells build their internal scaffolding. This is a legitimate biological molecule, not a made-up supplement.
TB4 promotes cell migration (how cells move to wound sites), angiogenesis (new blood vessel formation), and reduces inflammation through downregulation of inflammatory cytokines. These mechanisms are well-characterized in cell culture and animal models. The protein genuinely helps cells get where they need to go during tissue repair.
The most cited TB4 study is Bock-Marquette et al. (2004) published in Nature, showing that TB4 promoted survival of cardiac muscle cells and improved heart function after induced heart attacks in mice. This is real, significant research from a top-tier journal. However, mouse hearts regenerate differently than human hearts. No human cardiac repair trials with TB-500 have been completed.
TB-500 was banned in horse racing, which the internet interprets as proof it works miracles. The reality is more nuanced: it was banned because it was widely used and essentially undetectable, making fair competition impossible. The ban was a regulatory decision about detectability and widespread use, not necessarily a statement about extraordinary efficacy. Horses given TB-500 showed some improvement in soft tissue healing times, but the dramatic recovery stories are largely anecdotal.
Human trial data for TB-500 is far more limited than even BPC-157. Most published human research on Thymosin Beta-4 involves a different formulation (RGN-259) tested as eye drops for dry eye and neurotrophic keratitis — not the injectable TB-500 used by the biohacking community. Extrapolating eye drop results to systemic injection healing is a significant leap.
The practice of combining BPC-157 and TB-500 was invented by online peptide communities, not researchers. There are zero controlled studies examining this specific combination. The rationale — BPC-157 for local healing plus TB-500 for systemic healing — is logically appealing but scientifically unvalidated. Drug interactions, dose adjustments, and combined safety profiles are completely unknown.
A single study (Philp et al., 2004) showed TB4 activated hair follicle stem cells in mice, leading to new hair growth. This has been extrapolated into widespread claims of TB-500 as a hair loss treatment. One mouse study does not equal a proven hair regrowth therapy. No human hair loss trials have been conducted with TB-500.
The typical community protocol involves a loading phase of 2-5mg injected subcutaneously twice weekly for 4-6 weeks, followed by a maintenance phase of 2-5mg once weekly. These doses are extrapolated from animal studies using body surface area scaling and community anecdotal reports. There is no human dose-response data to validate these protocols.
Thymosin Beta-4 is a real, biologically important protein with well-characterized roles in cell migration, wound healing, and tissue repair. The cardiac repair data from mouse models is genuinely interesting and was published in Nature — that is not nothing. But the gap between mouse cardiac studies, horse racing anecdotes, and the claims made by online peptide communities is enormous. TB-500 has even less human clinical data than BPC-157. The “Wolverine Stack” combining the two is a community invention with zero controlled studies behind it. If you are using TB-500, you are running a self-experiment on a compound where the human evidence barely exists. That makes rigorous tracking of your recovery metrics, inflammation markers, injection sites, and side effects not optional — it is the only way to know whether what you are doing is actually working.
The published research behind TB-500 and Thymosin Beta-4. Note how much of it is preclinical.
The landmark study. Demonstrated TB4 promotes cardiomyocyte survival and functional recovery after myocardial infarction in mice. Published in Nature — the highest-impact journal in science.
Review of TB4 in ocular surface healing. RGN-259 (TB4 eye drops) showed efficacy in dry eye and neurotrophic keratitis trials. Most relevant human TB4 data, though route of administration differs from injectable TB-500.
Comprehensive review of TB4 biology: actin binding, cell migration, anti-inflammatory effects, and wound healing mechanisms. Good overview of the basic science foundation.
The mouse study behind TB-500 hair growth claims. Showed TB4 activated follicular stem cells in mice. No follow-up human trials have been conducted.
Broad review of TB4 as a regenerative peptide across tissue types. Discusses wound healing, cardiac repair, neuroprotection, and anti-inflammatory properties. Good entry point for understanding the full scope of TB4 research.
What people actually use. Community-reported protocols with no clinical validation.
2-5mg injected subcutaneously twice per week for 4-6 weeks. Injection sites typically include the abdomen or upper thigh. TB-500 is reconstituted from lyophilized powder with bacteriostatic water.
The loading phase is intended to build circulating levels. This protocol is community-derived. There is no published human pharmacokinetic data establishing optimal loading duration or frequency.
2-5mg injected subcutaneously once per week, ongoing or for 4-8 weeks after the loading phase. Some users reduce to biweekly injections during maintenance.
Maintenance dosing is meant to sustain effects. Cycle length and when to stop are entirely based on community anecdote. Some users cycle continuously; others take periodic breaks.
TB-500 2.5mg 2x/week + BPC-157 250-500mcg 1-2x/day, both injected subcutaneously. Loading for 4-6 weeks, then reduce to maintenance. Often injected at separate sites.
This combination is the most discussed peptide stack online. It has zero clinical evidence. No study has examined this combination for safety, interactions, or synergistic effects.
If you are running a TB-500 protocol, these are the metrics that will tell you whether it is actually doing anything.
Log range of motion, functional capacity (e.g., can you do a full squat, overhead press, walk without pain), and recovery time between training sessions. Use objective measures when possible — a goniometer for joint angles, a timer for functional tests.
If you have access to bloodwork, track CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate) before starting and at 4-week intervals. These are general inflammation markers that may shift if TB-500 is having a systemic anti-inflammatory effect.
Track injection locations on a body map. TB-500 is typically injected systemically (abdomen, thigh) rather than locally at injury sites. Monitor for redness, swelling, or hard lumps at injection points.
Daily pain scores at the target injury site using a consistent 0-10 scale. Note time of day, activity level, and any external factors (sleep quality, stress, other medications). Subjective improvement is meaningful but only if tracked consistently.
Record exact dose (in mg), injection time, reconstitution date, and cycle day. If you are stacking with other compounds, log each separately. This data is essential for identifying what is actually driving any changes you observe.
Some users report sleep quality improvements on TB-500. Track sleep duration, perceived quality, and daytime energy levels. Use a wearable if available for objective sleep stage data.
Often discussed alongside TB-500. Each has its own evidence profile.
Log every dose, track your recovery metrics, monitor inflammation markers, and let your data tell you what is actually working. Self-experimentation without data is just guessing.
Get Started Free →